Aratana Therapeutics - InvestorRoom https://aratana.investorroom.com/ Aratana Therapeutics to Report Second Quarter 2018 Financial Results https://aratana.investorroom.com/2018-07-10-Aratana-Therapeutics-to-Report-Second-Quarter-2018-Financial-Results Tue, 10 Jul 2018 08:30:00 -0400 https://aratana.investorroom.com/2018-07-10-Aratana-Therapeutics-to-Report-Second-Quarter-2018-Financial-Results Aratana Therapeutics Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion https://aratana.investorroom.com/2018-06-01-Aratana-Therapeutics-Files-for-FDA-Approval-of-NOCITA-R-bupivacaine-liposome-injectable-suspension-Label-Expansion Fri, 01 Jun 2018 08:30:00 -0400 https://aratana.investorroom.com/2018-06-01-Aratana-Therapeutics-Files-for-FDA-Approval-of-NOCITA-R-bupivacaine-liposome-injectable-suspension-Label-Expansion Aratana Therapeutics to Participate at Jefferies 2018 Global Healthcare Conference https://aratana.investorroom.com/2018-05-22-Aratana-Therapeutics-to-Participate-at-Jefferies-2018-Global-Healthcare-Conference Tue, 22 May 2018 16:05:00 -0400 https://aratana.investorroom.com/2018-05-22-Aratana-Therapeutics-to-Participate-at-Jefferies-2018-Global-Healthcare-Conference Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital https://aratana.investorroom.com/2018-05-21-Aratana-Therapeutics-Appoints-Craig-Barbarosh-and-Lowell-Robinson-to-its-Board-of-Directors-in-Cooperation-Agreement-with-Engaged-Capital Mon, 21 May 2018 08:30:00 -0400 https://aratana.investorroom.com/2018-05-21-Aratana-Therapeutics-Appoints-Craig-Barbarosh-and-Lowell-Robinson-to-its-Board-of-Directors-in-Cooperation-Agreement-with-Engaged-Capital Aratana Therapeutics Reports First Quarter 2018 Financial Results https://aratana.investorroom.com/2018-05-03-Aratana-Therapeutics-Reports-First-Quarter-2018-Financial-Results Thu, 03 May 2018 16:05:00 -0400 https://aratana.investorroom.com/2018-05-03-Aratana-Therapeutics-Reports-First-Quarter-2018-Financial-Results